Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,094.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (0.046%)
Market Cap: £9.25b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

9 Dec 2022 11:30

RNS Number : 2420J
Smith & Nephew Plc
09 December 2022
 

SMITH & NEPHEW PLC

 

9 December 2022

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

On 8 December 2022, the following award of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested under an award agreement to Deepak Nath. 

 

VESTING OF A PERFORMANCE AWARD GRANTED UNDER THE AWARD AGREEMENT DATED 29 APRIL 2022

 

As set out in the announcement published on 3 May 2022, a Performance Award over 127,461 shares was granted to Deepak Nath with an expected vest date of 9 November 2022. The vest of this award was subject to the performance conditions applicable to the performance stock award over Siemens Healthineers AG ("SH") shares originally granted to Deepak Nath by SH on 9 November 2018.

 

In accordance with the terms of the award agreement, the expected vest date of 9 November 2022 was delayed so that the applicable performance criteria attaching to the Performance Award could be measured against the financial results of SH which were announced on 23 November 2022. It has been determined that, following completion of the performance measurement period, 91.985% of the award vests. 117,245 shares were therefore available for vest with the remaining balance of shares, 10,216, lapsing with immediate effect.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Final vest of a Performance Award granted on 29 April 2022 under the award agreement.

Date of Transaction

2022 - 12 - 08

Place of Transaction

London Stock Exchange (XLON)

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Total Ordinary Share Holding following the transaction *

Total Ordinary Share Holding as a % of the Company's ISC following the transaction *

Deepak Nath

(Chief Executive Officer)

Director

10.96

117,245 (of which 28,650 were sold to cover taxes due and 88,595 retained)

N/A Single Transaction

97,784.00000 ordinary shares

0.01114%

 

 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLLFTLAIIF
Date   Source Headline
12th Mar 20191:00 pmRNSSmith & Nephew to acquire Osiris Therapeutics, Inc
8th Mar 20191:31 pmRNSDirector/PDMR Shareholding
8th Mar 20191:29 pmRNSDirector/PDMR Shareholding
8th Mar 20191:27 pmRNSDirector/PDMR Shareholding
4th Mar 20194:08 pmRNSAnnual Financial Report
4th Mar 20193:42 pmRNSAnnual Financial Report
1st Mar 201911:43 amRNSTotal Voting Rights
19th Feb 20193:08 pmRNSTransaction in Own Shares
15th Feb 20195:32 pmRNSTransaction in Own Shares
14th Feb 20195:37 pmRNSTransaction in Own Shares
14th Feb 20198:14 amRNSDirector Declaration
13th Feb 20195:17 pmRNSTransaction in Own Shares
12th Feb 20195:20 pmRNSTransaction in Own Shares
11th Feb 20195:41 pmRNSTransaction in Own Shares
8th Feb 20191:59 pmRNSTransaction in Own Shares
8th Feb 20199:20 amRNSDirector/PDMR Shareholding
8th Feb 20199:17 amRNSDirectorate Change
7th Feb 20197:00 amRNSFinal Results
1st Feb 20192:04 pmRNSBlock listing Interim Review
1st Feb 201912:06 pmRNSTotal Voting Rights
22nd Jan 20192:38 pmRNSSmith & Nephew acquires Ceterix Orthopaedics
16th Jan 20195:19 pmRNSDirector/PDMR Shareholding
11th Jan 20199:00 amRNSNotice of Results
7th Jan 20197:00 amRNSSmith & Nephew to present today at JP Morgan
4th Jan 20195:32 pmRNSSmith & Nephew at JP Morgan Healthcare Conference
2nd Jan 201911:19 amRNSTotal Voting Rights
18th Dec 20184:30 pmRNSAcquisition
7th Dec 201810:26 amRNSDirector/PDMR Shareholding
4th Dec 20184:20 pmRNSDirector/PDMR Shareholding
4th Dec 20184:18 pmRNSDirector/PDMR Shareholding
3rd Dec 201812:00 pmRNSTotal Voting Rights
26th Nov 20183:07 pmRNSTransaction in Own Shares
22nd Nov 201811:57 amRNSTransaction in Own Shares
21st Nov 20185:31 pmRNSTransaction in Own Shares
20th Nov 20185:18 pmRNSTransaction in Own Shares
19th Nov 20185:49 pmRNSTransaction in Own Shares
16th Nov 20182:19 pmRNSDirector/PDMR Shareholding
16th Nov 201810:21 amRNSDirector/PDMR Shareholding
16th Nov 20188:59 amRNSTransaction in Own Shares
14th Nov 20184:46 pmRNSDirector/PDMR Shareholding
12th Nov 20183:46 pmRNSDirector/PDMR Shareholding
9th Nov 20184:26 pmRNSDirector/PDMR Shareholding
6th Nov 20188:55 amRNSDirector/PDMR Shareholding
5th Nov 20188:24 amRNSDirector/PDMR Shareholding
1st Nov 20184:26 pmRNSDirector/PDMR Shareholding
1st Nov 20183:20 pmRNSDirector/PDMR Shareholding
1st Nov 20183:00 pmRNSTotal Voting Rights
1st Nov 20187:00 amRNSTrading Statement
31st Oct 20184:00 pmRNSDirector/PDMR Shareholding
18th Oct 20183:54 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.